Patent · US Active

Degraders of WEE1 kinase

US12318452B2 · kind B2 · utility

0Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 26, 2019
Grant dateJun 3, 2025
Priority date
Expiry dateAug 17, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/555
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are bifunctional compounds (degraders) that target Wee1 tyrosine kinase for degradation. Also disclosed are pharmaceutical compositions containing the degraders and methods of using the compounds to treat disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.